Dr Alexander Grossi, MD | |
16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075-4808 | |
(734) 233-8481 | |
Not Available |
Full Name | Dr Alexander Grossi |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 18 Years |
Location | 16000 W 9 Mile Rd, Southfield, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134248974 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 4301087569 (Michigan) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northwestern Services Llc | 4486723657 | 37 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Entity Name | Northland Anesthesia Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528001880 PECOS PAC ID: 5294623336 Enrollment ID: O20040309001092 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Entity Name | Northwestern Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215106679 PECOS PAC ID: 4486723657 Enrollment ID: O20080514000823 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Entity Name | Providence Park Anesthesia Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942459672 PECOS PAC ID: 7315009479 Enrollment ID: O20081224000115 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Entity Name | Eastside Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235365289 PECOS PAC ID: 4486790219 Enrollment ID: O20091008000624 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Entity Name | Detroit Anesthesia Group Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316212988 PECOS PAC ID: 3173789088 Enrollment ID: O20120723000043 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Entity Name | Novi Aas Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598176919 PECOS PAC ID: 1557587847 Enrollment ID: O20140722002052 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alexander Grossi, MD 16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075-4808 Ph: (734) 233-8481 | Dr Alexander Grossi, MD 16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075-4808 Ph: (734) 233-8481 |
News Archive
Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.
The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
› Verified 8 days ago
Jonathan Arie Kroll, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Dominick Lago Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Jeffrey Joseph Kirouac, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Leslie A Mumaw, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26051 Lahser Rd, Southfield, MI 48034 Phone: 248-223-9945 | |
Mark Mounayer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26025 Lahser Rd Fl 3, Southfield, MI 48033 Phone: 248-663-1900 Fax: 248-663-1901 | |
Shad Siddiqi, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22250 Providence Dr Ste 401, Southfield, MI 48075 Phone: 866-974-2673 Fax: 866-939-2673 |